ptx_8k.htm
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): July 22, 2010
 
PERNIX THERAPEUTICS HOLDINGS, INC.
(Exact name of registrant as specified in its charter)
         
Maryland
  
001-14494
  
33-0724736
(State or other jurisdiction
 of incorporation)
  
(Commission File Number)
  
(IRS Employer Identification No.)

     
33219 Forest West Street
 Magnolia, TX
  
 
77354
(Address of principal executive offices)
  
(Zip Code)
 
Registrant’s telephone number, including area code: (832) 934-1825
 
__________________________________________________________________
 (Former name or former address, if changed since last report.)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 

o
  
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
o
  
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
o
  
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
o
  
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 

 

 
 
 

Item 5.07        Submission of Matters to a Vote of Security Holders
 
    The annual meeting of stockholders of Pernix Therapeutics Holdings, Inc. (the “Company”) was held on July 22, 2010.  At the annual meeting, our stockholders (i) elected each nominee to serve as a Company director until the next annual meeting of stockholders, (ii) adopted the Pernix Therapeutics Holdings, Inc. 2010 Employee Stock Purchase Plan (“Stock Purchase Plan”) and (iii) approved the appointment of Cherry, Bekaert & Holland, L.L.P. as our independent registered public accounting firm for fiscal 2010.
 
    The final voting tabulation for the election of directors was as follows:
 

Nominee
Number of Votes For
Number of Votes Withheld
Michael C. Pearce
20,900,360
-
Cooper C. Collins
20,900,360
-
Anthem Blanchard
20,900,360
-
Jan H. Loeb
20,900,360
-
James E. Smith, Jr.
20,900,360
-
 

 
The final voting tabulation for the ratification of the independent registered public accounting firm and the approval of the Stock Purchase Plan was as follows:
 

Proposals
Number of Votes For
Number of Votes
Against
Abstentions
  
Ratification Cherry, Bekaert & Holland, L.L.P.
20,900,360
-
-
  
         
Approval of the Pernix Therapeutics Holdings, Inc. 2010 Employee Stock Purchase Plan
20,900,360
-
-
  

 


 
 
 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
  PERNIX THERAPEUTICS HOLDINGS, INC.  
       
Dated:  July 26, 2010
By:
/s/ Tracy Clifford  
    Tracy Clifford  
    Chief Financial Officer